Cargando…
FGF23 protects osteoblasts from dexamethasone-induced oxidative injury
Dexamethasone (DEX) can exert a cytotoxic effect on cultured osteoblasts. The current study explored the potential osteoblast cytoprotective effect of fibroblast growth factor 23 (FGF23). In OB-6 human osteoblastic cells and primary murine osteoblasts, FGF23 induced phosphorylation of the receptor F...
Autores principales: | Ji, Feng, Hu, Xiaohui, Hu, Wenhao, Hao, Yue-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732311/ https://www.ncbi.nlm.nih.gov/pubmed/33052883 http://dx.doi.org/10.18632/aging.103689 |
Ejemplares similares
-
microRNA-19a protects osteoblasts from dexamethasone via targeting TSC1
por: Liu, Gang, et al.
Publicado: (2017) -
MicroRNA-200a activates Nrf2 signaling to protect osteoblasts from dexamethasone
por: Zhao, Sai, et al.
Publicado: (2017) -
miR-107 inhibition upregulates CAB39 and activates AMPK-Nrf2 signaling to protect osteoblasts from dexamethasone-induced oxidative injury and cytotoxicity
por: Zhuang, Yu, et al.
Publicado: (2020) -
Icariside II activates EGFR-Akt-Nrf2 signaling and protects osteoblasts from dexamethasone
por: Liu, Weidong, et al.
Publicado: (2016) -
Activation of Nrf2 by MIND4-17 protects osteoblasts from hydrogen peroxide-induced oxidative stress
por: Guo, Shiguang, et al.
Publicado: (2017)